Antiviral Treatment of Patients with Recurrent Hepatitis C After Liver Transplantation with Pegylated Interferon (original) (raw)

Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation

patricia hilgard, Speranta Iacob

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

An extended treatment protocol with pegylated interferon and ribavirin for hepatitis C recurrence after liver transplantation

Eyob Feyssa

World Journal of Hepatology, 2011

View PDFchevron_right

Efficacy of an escalating dose regimen of pegylated interferon ?-2a plus ribavirin in the early phase of HCV reinfection after liver transplantation

Gertrud Greif-Higer

Transplant International, 2007

View PDFchevron_right

Treatment of Established Recurrent Hepatitis C in Liver-Transplant Recipients with Pegylated Interferon-alfa-2b and Ribavirin Therapy

Maria Isabel Gil Medina

Transplantation, 2004

View PDFchevron_right

Pegylated interferon-alpha 2a /ribavirin treatment of recurrent hepatitis C after liver transplantation

Jean-francois Dufour

Transplant Infectious Disease, 2009

View PDFchevron_right

Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation

Enrique Moreno

Liver Transplantation, 2006

View PDFchevron_right

Hepatitis C Recurrence After Liver Transplantation: Viral and Histologic Response to Full-Dose Peg-Interferon and Ribavirin

Valentin Cuervas-mons

American Journal of Transplantation, 2006

View PDFchevron_right

Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C

James Crawford

Liver Transplantation, 2004

View PDFchevron_right

Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin treatment

Ferruccio Bonino

Transplantation Proceedings, 2001

View PDFchevron_right

Antiviral Therapy for Hepatitis C Virus Recurrence Following Liver Transplantation: Long-Term Results From a Single Center Experience

Patrizia Burra

Transplantation Proceedings, 2006

View PDFchevron_right

Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation

Sandeep Mukherjee

Transplantation …, 2003

View PDFchevron_right

Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. A long-term follow-up

Detlef Schuppan

View PDFchevron_right

Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin* 1

Maurizio Fadda

Journal of …, 2002

View PDFchevron_right

Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation

Franco Lodato

Alimentary Pharmacology & Therapeutics, 2008

View PDFchevron_right

Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C

Raymond Pascual

Clinical Transplantation, 2004

View PDFchevron_right

Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin

Maurizio Fadda

Journal of Hepatology, 2002

View PDFchevron_right

Pegylated interferon α‐2b plus ribavirin in the treatment of post‐liver transplant recurrent hepatitis C

Sarah Hakem

Clinical Transplantation, 2004

View PDFchevron_right

Increased duration of dual pegylated interferon and ribavirin therapy for genotype 1 hepatitis C Post-liver transplantation increases sustained virologic response: A retrospective review

Malcolmm Wells

Saudi Journal of Gastroenterology, 2013

View PDFchevron_right

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin

Susan Orloff

Liver Transplantation, 2001

View PDFchevron_right

Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence

Grace L Su

Liver Transplantation, 2007

View PDFchevron_right